ACMT Position Statement: Role of the Medical Toxicologist in the Management of Patients with Substance Use Disorder

Affiliations

¹ Johns Hopkins University School of Medicine, Baltimore, MD, USA. positionstatements@acmt.net.
² MedStar Washington Hospital Center, Washington, DC, USA.
³ Jackson Memorial Hospital, Miami, FL, USA.
⁴ Department of Emergency Medicine, Wright State University Boonshoft School of Medicine, Dayton, OH, USA.
⁵ Rutgers New Jersey Medical School, Newark, NJ, USA.
⁶ Departments of Emergency Medicine & Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
⁷ National Institute On Drug Abuse, Bethesda, MD, USA.
⁸ National Institutes of Health, Bethesda, MD, USA.
⁹ University of New Mexico School of Medicine, NM, Albuquerque, USA.
¹⁰ American College of Medical Toxicology, Phoenix, AZ, USA.

Andrew I Stolbach et al. J Med Toxicol. 2023 Oct.

. 2023 Oct;19(4):411-413.

doi: 10.1007/s13181-023-00945-3. Epub 2023 Jul 6.

¹ Johns Hopkins University School of Medicine, Baltimore, MD, USA. positionstatements@acmt.net.
² MedStar Washington Hospital Center, Washington, DC, USA.
³ Jackson Memorial Hospital, Miami, FL, USA.
⁴ Department of Emergency Medicine, Wright State University Boonshoft School of Medicine, Dayton, OH, USA.
⁵ Rutgers New Jersey Medical School, Newark, NJ, USA.
⁶ Departments of Emergency Medicine & Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
⁷ National Institute On Drug Abuse, Bethesda, MD, USA.
⁸ National Institutes of Health, Bethesda, MD, USA.
⁹ University of New Mexico School of Medicine, NM, Albuquerque, USA.
¹⁰ American College of Medical Toxicology, Phoenix, AZ, USA.

No abstract available

Keywords: Addiction medicine; Medical toxicologist; Opioid epidemic; Substance use disorder.

Conflict of interest statement

Dr. Weiss is supported by the Intramural Research Program of the NIH, NIDA.

1. Centers for Disease Control and Prevention. U.S. overdose deaths in 2021 increased half as much as in 2020-but are still up 15%. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/202205.htm. Accessed 12/23/22.
1. Suen LW, Makam AN, Snyder HR, Repplinger D, Kushel MB, Martin M, Nguyen OK. National prevalence of alcohol and other substance use disorders among emergency department visits and hospitalizations: NHAMCS 2014–2018. J Gen Intern Med. 2022;37(10):2420–2428. doi: 10.1007/s11606-021-07069-w. - DOI - PMC - PubMed
1. Cernasev A, Hohmeier KC, Frederick K, Jasmin H, Gatwood J. A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder. Explor Res Clin Soc Pharm. 2021;2:100029. doi: 10.1016/j.rcsop.2021.100029. - DOI - PMC - PubMed
1. Saloner B, Li W, Bandara SN, McGinty EE, Barry CL. Trends in the use of treatment for substance use disorders, 2010–19. Health Aff (Millwood) 2022;41(5):696–702. doi: 10.1377/hlthaff.2021.01767. - DOI - PMC - PubMed
1. Greater New York Hospital Association. The Opioid Workforce Act of 2021. https://www.gnyha.org/position/opioid-workforce-act/. Accessed 1 June 2023.